The field of breast cancer is ever advancing, with more and more treatments becoming available, resulting in better outcomes for our patients. The management of HER2 positive breast cancer in particular has taken tremendous strides over the last year or so. On this course we aim to discuss the evidence behind why we manage HER2 positive breast cancer the way we do in both the early and metastatic settings.
We also invite delegates to submit or present any challenging cases they have encountered in their own practice to reflect and share their learning with others.
This course is free to attend. To register please visit: HER-2 Positive Breast Cancer Course